Maintaining Quality and Bioethics through ISO, AABB, and Ethics Committee Oversight
First written in FY2021. 3 of 4 entries say "Restated". Latest entry: FY2025.
0 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「The company began operating under ISO 9001 in 2011 to improve the quality of umbilical cord blood storage. To comply with global standards, it obtained AABB accreditation for umbilical cord blood storage in July 2019.」
The company continues its policy of managing quality, safety and bioethics through ISO 9001, AABB and its internal Ethics Committee, among other measures. - FY2023RestatedAnnual report
「The company began operating under ISO 9001 in 2011 to improve the quality of umbilical cord blood storage. To comply with global standards, it obtained AABB accreditation for umbilical cord blood storage in July 2019.」
The company continues its policy of managing quality, safety and bioethics based on ISO 9001, AABB, its internal Ethics Committee and quality management standards. - FY2022RestatedAnnual report
「The company began operating under ISO 9001 in 2011 to improve the quality of umbilical cord blood storage. To comply with global standards, it obtained AABB accreditation for umbilical cord blood storage in July 2019.」
The company continues its policy of managing quality, safety and bioethics through ISO 9001, AABB and its internal Ethics Committee, among other measures. - FY2021First statedAnnual report
「The company began operating under ISO 9001 in 2011 to improve the quality of umbilical cord blood storage. To comply with global standards, it obtained AABB accreditation for umbilical cord blood storage in July 2019.」
The company continuously manages cell quality, safety and compliance with laws and regulations through ISO 9001, AABB, its internal Ethics Committee and deliberations by specialized committee members.